A detailed history of Saturna Capital Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Saturna Capital Corp holds 24,850 shares of BSX stock, worth $1.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,850
Previous 23,600 5.3%
Holding current value
$1.9 Million
Previous $1.36 Million 24.71%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $72,000 - $85,775
1,250 Added 5.3%
24,850 $1.7 Million
Q4 2023

Feb 06, 2024

BUY
$48.64 - $57.81 $32,832 - $39,021
675 Added 2.94%
23,600 $1.36 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $46,425 - $50,579
925 Added 4.2%
22,925 $1.21 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $450,900 - $500,300
10,000 Added 83.33%
22,000 $1.1 Million
Q4 2022

Feb 09, 2023

BUY
$39.56 - $47.22 $474,720 - $566,640
12,000 New
12,000 $555,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.